These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24913310)

  • 1. The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale.
    Cosconati S; Novellino E
    J Med Chem; 2014 Jun; 57(12):5072-3. PubMed ID: 24913310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
    Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
    J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats.
    Harris CM; Mittelstadt S; Banfor P; Bousquet P; Duignan DB; Gintant G; Hart M; Kim Y; Segreti J
    J Pharmacol Exp Ther; 2016 Oct; 359(1):151-8. PubMed ID: 27519818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency.
    Sunter G; Enver EO; Akbarzade A; Turan S; Vatansever P; Gunal DI; Haklar G; Bereket A; Agan K; Guran T
    BMC Neurol; 2018 Apr; 18(1):48. PubMed ID: 29685115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
    Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).
    Sanllehí P; Abad JL; Casas J; Delgado A
    Chem Phys Lipids; 2016 May; 197():69-81. PubMed ID: 26200919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.
    Ohtoyo M; Tamura M; Machinaga N; Muro F; Hashimoto R
    Lipids; 2016 Oct; 51(10):1207-1216. PubMed ID: 27585475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
    Schümann J; Grevot A; Ledieu D; Wolf A; Schubart A; Piaia A; Sutter E; Côté S; Beerli C; Pognan F; Billich A; Moulin P; Walker UJ
    Toxicol Pathol; 2015 Jul; 43(5):694-703. PubMed ID: 25630683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of the sphingosine-1-phosphate signalling system.
    Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
    Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
    Dinges J; Harris CM; Wallace GA; Argiriadi MA; Queeney KL; Perron DC; Dominguez E; Kebede T; Desino KE; Patel H; Vasudevan A
    Bioorg Med Chem Lett; 2016 May; 26(9):2297-302. PubMed ID: 27020302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors.
    Sanllehí P; Abad JL; Casas J; Bujons J; Delgado A
    Bioorg Med Chem; 2016 Sep; 24(18):4381-4389. PubMed ID: 27475537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
    Pons G; Riba D; Casasampere M; Izquierdo E; Abad JL; Fabriàs G; Rodríguez Ortega PG; López-González JJ; Montejo M; Casas J; Delgado A
    J Org Chem; 2020 Jan; 85(2):419-429. PubMed ID: 31860798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
    Loetscher E; Schneider K; Beerli C; Billich A
    Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei.
    Custódio R; McLean CJ; Scott AE; Lowther J; Kennedy A; Clarke DJ; Campopiano DJ; Sarkar-Tyson M; Brown AR
    Mol Microbiol; 2016 Dec; 102(6):1004-1019. PubMed ID: 27632710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bioassay Using a Pentadecanal Derivative to Measure S1P Lyase Activity.
    Shin KO; Shamshiddinova M; Lee JN; Lee KS; Lee YM
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy.
    Huang LS; Berdyshev EV; Tran JT; Xie L; Chen J; Ebenezer DL; Mathew B; Gorshkova I; Zhang W; Reddy SP; Harijith A; Wang G; Feghali-Bostwick C; Noth I; Ma SF; Zhou T; Ma W; Garcia JG; Natarajan V
    Thorax; 2015 Dec; 70(12):1138-48. PubMed ID: 26286721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932).
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Carlsen M; Jessop TC; Tarver J; Aleem S; Dong L; Zhang H; Boteju L; Hazelwood J; Yan J; Bednarz M; Layek S; Owusu IB; Gopinathan S; Moran L; Lai Z; Kramer J; Kimball SD; Yalamanchili P; Heydorn WE; Frazier KS; Brooks B; Brown P; Wilson A; Sonnenburg WK; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2010 Dec; 53(24):8650-62. PubMed ID: 21090716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.